GPhC welcomes audit on valproate medicines safety in community pharmacy
Duncan Rudkin, Chief Executive of the GPhC said:
“The CCA’s findings provide evidence of some improvement between 2018 and 2019 in terms of pharmacy teams’ awareness of the need to follow the Pregnancy Prevention Programme (PPP) for valproate, but it is clear there is still more to be done.
Recent Comments